Alto Neuroscience (ANRO) news
Recent news
United Therapeutics Corp - Liquidia to terminate ascent trial cohorts studying PH-ILD and cease data publication - SEC filing
AInvest Wire · 1d agoPayward-Saldo deal seen closing in 2027
The anticipated merger between Payward and Saldo, two prominent players in the digital payments sector, is expected to finalize in 2027, according to recent regulatory filings and internal communications from both companies. The deal, which has been under review by antitrust authorities since early…
AInvest Wire · 1d agoJapan's Onron to buy OnLogic for around 100B yen: Nikkei
AInvest Wire · 2d agoAlto Neuroscience - Promotes Nick Smith to president and CFO effective August 26, 2026
AInvest Wire · Aug 27, 2026Alto Neuroscience - proceeds to accelerate clinical development of Alto-207 and for working capital
Alto Neuroscience Inc. (NASDAQ: ALTO) has announced a $45 million equity financing round to support the accelerated clinical development of its lead candidate, Alto-207, and to strengthen its working capital position [1]. The financing includes participation from existing institutional investors…
AInvest Wire · Jul 13, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.